-
1
-
-
34250706406
-
Cancer and thrombosis: From molecular mechanisms to clinical presentations
-
suppl 1. 10.1111/j.1538-7836.2007.02497.x
-
HR Büller FF Van Doornmaal GL Van Sluis 2007 Cancer and thrombosis: from molecular mechanisms to clinical presentations J Thromb Haemost 5 suppl 1 246 254 10.1111/j.1538-7836.2007.02497.x
-
(2007)
J Thromb Haemost
, vol.5
, pp. 246-254
-
-
Büller, H.R.1
Van Doornmaal, F.F.2
Van Sluis, G.L.3
-
2
-
-
13444256137
-
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
-
10.1001/jama.293.6.715
-
JW Blom CJM Doggen S Osanto 2005 Malignancies, prothrombotic mutations, and the risk of venous thrombosis J Am Med Assoc 293 715 722 10.1001/jama.293.6.715
-
(2005)
J Am Med Assoc
, vol.293
, pp. 715-722
-
-
Blom, J.W.1
Doggen, C.J.M.2
Osanto, S.3
-
3
-
-
33847291915
-
Mechanisms of heparin induced anti-cancer activity in experimental cancer models
-
10.1016/j.critrevonc.2006.07.007
-
TM Niers CP Klerk M Dinisio 2007 Mechanisms of heparin induced anti-cancer activity in experimental cancer models Crit Rev Oncol/Hematol 61 195 207 10.1016/j.critrevonc.2006.07.007
-
(2007)
Crit Rev Oncol/Hematol
, vol.61
, pp. 195-207
-
-
Niers, T.M.1
Klerk, C.P.2
Dinisio, M.3
-
4
-
-
0035109328
-
The complex effects of heparins on cancer progression and metastasis in experimental studies
-
SM Smorenburg CJ Van Noorden 2001 The complex effects of heparins on cancer progression and metastasis in experimental studies Pharmacol Rev 53 93 105
-
(2001)
Pharmacol Rev
, vol.53
, pp. 93-105
-
-
Smorenburg, S.M.1
Van Noorden, C.J.2
-
5
-
-
12844289104
-
A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer
-
10.1111/j.1538-7836.2004.00871.x
-
M Altinbas HS Coskun O Er 2004 A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer J Thromb Haemost 2 1266 1271 10.1111/j.1538-7836.2004.00871.x
-
(2004)
J Thromb Haemost
, vol.2
, pp. 1266-1271
-
-
Altinbas, M.1
Coskun, H.S.2
Er, O.3
-
6
-
-
3042704507
-
Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: The fragmin advanced malignancy outcome study (FAMOUS)
-
10.1200/JCO.2004.10.002
-
AK Kakkar MN Levine Z Kadziola 2004 Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS) J Clin Oncol 22 1944 1948 10.1200/JCO.2004.10. 002
-
(2004)
J Clin Oncol
, vol.22
, pp. 1944-1948
-
-
Kakkar, A.K.1
Levine, M.N.2
Kadziola, Z.3
-
7
-
-
20244376337
-
The effect of low molecular weight heparin on survival in patients with advanced malignancy
-
10.1200/JCO.2005.03.134
-
CP Klerk SM Smorenburg HM Otten 2005 The effect of low molecular weight heparin on survival in patients with advanced malignancy J Clin Oncol 23 2130 2135 10.1200/JCO.2005.03.134
-
(2005)
J Clin Oncol
, vol.23
, pp. 2130-2135
-
-
Klerk, C.P.1
Smorenburg, S.M.2
Otten, H.M.3
-
8
-
-
0028239146
-
Subcutaneous heparin treatment increases survival in small cell lung cancer. "petites Cellules" Group
-
10.1002/1097-0142(19940701)74:1<38::AID-CNCR2820740108>3.0. CO;2-E
-
B Lebeau C Chastang JM Brechot 1994 Subcutaneous heparin treatment increases survival in small cell lung cancer. "Petites Cellules" Group Cancer 74 38 45 10.1002/1097-0142(19940701)74:1<38::AID- CNCR2820740108>3.0.CO;2-E
-
(1994)
Cancer
, vol.74
, pp. 38-45
-
-
Lebeau, B.1
Chastang, C.2
Brechot, J.M.3
-
9
-
-
0037775584
-
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
-
10.1056/NEJMoa025313
-
AY Lee MN Levine RI Baker 2003 Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer The New Engl J Med 349 146 153 10.1056/NEJMoa025313
-
(2003)
The New Engl J Med
, vol.349
, pp. 146-153
-
-
Lee, A.Y.1
Levine, M.N.2
Baker, R.I.3
-
10
-
-
0037567437
-
Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism
-
TA Hembrough GM Swartz A Papathanassiu 2003 Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism Cancer Res 63 2997 3000
-
(2003)
Cancer Res
, vol.63
, pp. 2997-3000
-
-
Hembrough, T.A.1
Swartz, G.M.2
Papathanassiu, A.3
-
11
-
-
27844610322
-
Effective inhibition of experimental metastasis and prolongation of survival in mice by a potent factor Xa-specific synthetic serine protease inhibitor with weak anticoagulant activity
-
IJ Banke MJ Arlt MM Mueller 2005 Effective inhibition of experimental metastasis and prolongation of survival in mice by a potent factor Xa-specific synthetic serine protease inhibitor with weak anticoagulant activity Thromb Haemost 94 1084 1093
-
(2005)
Thromb Haemost
, vol.94
, pp. 1084-1093
-
-
Banke, I.J.1
Arlt, M.J.2
Mueller, M.M.3
-
12
-
-
7244231210
-
Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis
-
10.1182/blood-2004-03-1047
-
L Hu M Lee W Campbell 2004 Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis Blood 104 2746 2751 10.1182/blood-2004-03-1047
-
(2004)
Blood
, vol.104
, pp. 2746-2751
-
-
Hu, L.1
Lee, M.2
Campbell, W.3
-
13
-
-
0034669975
-
Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells
-
JS Palumbo KW Kombrinck AF Drew 2000 Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells Blood 96 3302 3309
-
(2000)
Blood
, vol.96
, pp. 3302-3309
-
-
Palumbo, J.S.1
Kombrinck, K.W.2
Drew, A.F.3
-
14
-
-
0028932993
-
Tissue factor pathway inhibitor and the revised theory of coagulation
-
10.1146/annurev.med.46.1.103
-
GJ Broze Jr 1995 Tissue factor pathway inhibitor and the revised theory of coagulation Ann Rev Med 46 103 112 10.1146/annurev.med.46.1.103
-
(1995)
Ann Rev Med
, vol.46
, pp. 103-112
-
-
Broze Jr, G.J.1
-
15
-
-
55249109293
-
Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders
-
PMID: 18363839
-
Brüggemann LW, Versteeg HH, Niers TM et al (2008) Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders. J Cell Mol Med (PMID: 18363839)
-
(2008)
J Cell Mol Med
-
-
Brüggemann, L.W.1
Versteeg, H.H.2
Niers, T.M.3
-
16
-
-
34547252606
-
Colon cancer metastasis in mouse liver is not affected by hypercoagulability due to Factor v Leiden mutation
-
10.1111/j.1582-4934.2007.00046.x
-
CP Klerk SM Smorenburg CA Spek 2007 Colon cancer metastasis in mouse liver is not affected by hypercoagulability due to Factor V Leiden mutation J Cell Mol Med 11 561 568 10.1111/j.1582-4934.2007.00046.x
-
(2007)
J Cell Mol Med
, vol.11
, pp. 561-568
-
-
Klerk, C.P.1
Smorenburg, S.M.2
Spek, C.A.3
-
17
-
-
26444566779
-
Differential metastasis inhibition by clinically relevant levels of heparins-correlation with selectin inhibition, not antithrombotic activity
-
10.1158/1078-0432.CCR-05-1131
-
JL Stevenson SH Choi A Varki 2005 Differential metastasis inhibition by clinically relevant levels of heparins-correlation with selectin inhibition, not antithrombotic activity Clin Cancer Res 11 7003 7011 10.1158/1078-0432.CCR-05- 1131
-
(2005)
Clin Cancer Res
, vol.11
, pp. 7003-7011
-
-
Stevenson, J.L.1
Choi, S.H.2
Varki, A.3
-
18
-
-
33645542177
-
The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo
-
RJ Ludwig S Alban R Bistrian WH Boehncke R Kaufmann R Henschler J Gille 2006 The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo Thromb Haemost 95 535 540
-
(2006)
Thromb Haemost
, vol.95
, pp. 535-540
-
-
Ludwig, R.J.1
Alban, S.2
Bistrian, R.3
Boehncke, W.H.4
Kaufmann, R.5
Henschler, R.6
Gille, J.7
-
19
-
-
36049013035
-
Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects
-
suppl 2. 10.1016/S0049-3848(07)70138-X
-
JL Stevenson A Varki L Borsig 2007 Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects Thromb Res 120 suppl 2 S107 S111 10.1016/S0049-3848(07)70138- X
-
(2007)
Thromb Res
, vol.120
-
-
Stevenson, J.L.1
Varki, A.2
Borsig, L.3
-
20
-
-
0035853111
-
Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis
-
10.1073/pnas.061615598
-
L Borsig R Wong J Feramisco 2001 Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis Proc Natl Acad Sci USA 98 3352 3357 10.1073/pnas.061615598
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 3352-3357
-
-
Borsig, L.1
Wong, R.2
Feramisco, J.3
-
21
-
-
0036194522
-
Mechanisms of action of proteinase-activated receptor agonists on human platelets
-
10.1038/sj.bjp.0704559
-
AW Chung P Jurasz MD Hollenberg 2002 Mechanisms of action of proteinase-activated receptor agonists on human platelets Br J Pharmacol 135 1123 1132 10.1038/sj.bjp.0704559
-
(2002)
Br J Pharmacol
, vol.135
, pp. 1123-1132
-
-
Chung, A.W.1
Jurasz, P.2
Hollenberg, M.D.3
-
22
-
-
0033559805
-
Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin
-
10.1172/JCI6042
-
ML Kahn M Nakanishi-Matsui MJ Shapiro 1999 Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin J Clin Invest 103 879 887 10.1172/JCI6042
-
(1999)
J Clin Invest
, vol.103
, pp. 879-887
-
-
Kahn, M.L.1
Nakanishi-Matsui, M.2
Shapiro, M.J.3
-
23
-
-
0037231665
-
Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein e
-
10.1038/nm810
-
Y Huo A Schober SB Forlow 2003 Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E Nat Med 9 61 67 10.1038/nm810
-
(2003)
Nat Med
, vol.9
, pp. 61-67
-
-
Huo, Y.1
Schober, A.2
Forlow, S.B.3
-
24
-
-
0023009601
-
Morphometric evaluation of thrombogenesis by microvesicles from human tumor cell lines with thrombin-dependent (U87MG) and adenosine diphosphate-dependent (SKNMC) platelet-activating mechanisms
-
E Bastida G Escolar A Ordinas 1986 Morphometric evaluation of thrombogenesis by microvesicles from human tumor cell lines with thrombin-dependent (U87MG) and adenosine diphosphate-dependent (SKNMC) platelet-activating mechanisms J Lab Clin Med 108 622 627
-
(1986)
J Lab Clin Med
, vol.108
, pp. 622-627
-
-
Bastida, E.1
Escolar, G.2
Ordinas, A.3
-
25
-
-
0023195437
-
Platelet aggregating activity mediated by thrombin generation in the NCG human neuroblastoma cell line
-
N Esumi S Todo S Imashuku 1987 Platelet aggregating activity mediated by thrombin generation in the NCG human neuroblastoma cell line Cancer Res 47 2129 2135
-
(1987)
Cancer Res
, vol.47
, pp. 2129-2135
-
-
Esumi, N.1
Todo, S.2
Imashuku, S.3
-
26
-
-
0028799219
-
Tumor cell-induced platelet aggregation in vitro by human pancreatic cancer cell lines
-
10.3109/00365529509096346
-
E Heinmoller T Schropp O Kisker 1995 Tumor cell-induced platelet aggregation in vitro by human pancreatic cancer cell lines Scand J Gastroenterol 30 1008 1016 10.3109/00365529509096346
-
(1995)
Scand J Gastroenterol
, vol.30
, pp. 1008-1016
-
-
Heinmoller, E.1
Schropp, T.2
Kisker, O.3
-
27
-
-
0034326271
-
Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro
-
A Collen SM Smorenburg E Peters 2000 Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro Cancer Res 60 6196 6200
-
(2000)
Cancer Res
, vol.60
, pp. 6196-6200
-
-
Collen, A.1
Smorenburg, S.M.2
Peters, E.3
-
28
-
-
0020688930
-
Fibrin as a component of the tumor stroma: Origins and biological significance
-
10.1007/BF00046905
-
HF Dvorak DR Senger AM Dvorak 1983 Fibrin as a component of the tumor stroma: origins and biological significance Cancer Metastas Rev 2 41 73 10.1007/BF00046905
-
(1983)
Cancer Metastas Rev
, vol.2
, pp. 41-73
-
-
Dvorak, H.F.1
Senger, D.R.2
Dvorak, A.M.3
-
29
-
-
0017704436
-
Metastasis results from preexisting variant cells within a malignant tumor
-
10.1126/science.887927
-
IJ Fidler ML Kripke 1977 Metastasis results from preexisting variant cells within a malignant tumor Science 197 893 895 10.1126/science.887927
-
(1977)
Science
, vol.197
, pp. 893-895
-
-
Fidler, I.J.1
Kripke, M.L.2
-
30
-
-
36048974449
-
Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals
-
doi: 10.2144/000112515
-
Klerk CP, Overmeer RM, Niers TM et al (2007) Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals. BioTechniques 43(Suppl):7-13. doi: 10.2144/000112515
-
(2007)
BioTechniques
, vol.43
, Issue.SUPPL
, pp. 7-13
-
-
Klerk, C.P.1
Overmeer, R.M.2
Niers, T.M.3
-
31
-
-
33845193498
-
Development of luciferase tagged brain tumour models in mice for chemotherapy intervention studies
-
10.1016/j.ejca.2006.07.013
-
EM Kemper W Leenders B Kusters 2006 Development of luciferase tagged brain tumour models in mice for chemotherapy intervention studies Eur J Cancer 42 3294 3303 10.1016/j.ejca.2006.07.013
-
(2006)
Eur J Cancer
, vol.42
, pp. 3294-3303
-
-
Kemper, E.M.1
Leenders, W.2
Kusters, B.3
-
32
-
-
0015289743
-
Coagulant activity of leukocytes. Tissue factor activity
-
10.1172/JCI106815
-
J Niemetz 1972 Coagulant activity of leukocytes. Tissue factor activity J Clin Invest 51 307 313 10.1172/JCI106815
-
(1972)
J Clin Invest
, vol.51
, pp. 307-313
-
-
Niemetz, J.1
-
33
-
-
0031927754
-
Thrombin receptor overexpression in malignant and physiological invasion processes
-
10.1038/nm0898-909
-
S Even-Ram B Uziely P Cohen 1998 Thrombin receptor overexpression in malignant and physiological invasion processes Nat Med 4 909 914 10.1038/nm0898-909
-
(1998)
Nat Med
, vol.4
, pp. 909-914
-
-
Even-Ram, S.1
Uziely, B.2
Cohen, P.3
-
34
-
-
21544440159
-
Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma
-
10.1016/j.humpath.2005.04.008
-
D Massi A Naldini C Ardinghi 2005 Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma Hum Pathol 36 676 685 10.1016/j.humpath.2005.04.008
-
(2005)
Hum Pathol
, vol.36
, pp. 676-685
-
-
Massi, D.1
Naldini, A.2
Ardinghi, C.3
-
35
-
-
0037783286
-
Human protease-activated receptor 1 expression in malignant epithelia: A role in invasiveness
-
10.1161/01.ATV.0000066878.27340.22
-
YJ Yin Z Salah S Grisaru-Granovsky 2003 Human protease-activated receptor 1 expression in malignant epithelia: a role in invasiveness Arterioscler Thromb Vasc Biol 23 940 944 10.1161/01.ATV.0000066878.27340.22
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 940-944
-
-
Yin, Y.J.1
Salah, Z.2
Grisaru-Granovsky, S.3
-
36
-
-
0026029064
-
Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo
-
10.1172/JCI114976
-
ML Nierodzik A Plotkin F Kajumo 1991 Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo J Clin Invest 87 229 236 10.1172/JCI114976
-
(1991)
J Clin Invest
, vol.87
, pp. 229-236
-
-
Nierodzik, M.L.1
Plotkin, A.2
Kajumo, F.3
-
37
-
-
0026684801
-
Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo
-
ML Nierodzik F Kajumo S Karpatkin 1992 Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo Cancer Res 52 3267 3272
-
(1992)
Cancer Res
, vol.52
, pp. 3267-3272
-
-
Nierodzik, M.L.1
Kajumo, F.2
Karpatkin, S.3
-
38
-
-
0026479936
-
Thrombin enhances tumor cell adhesive and metastatic properties via increased alpha IIb beta 3 expression on the cell surface
-
10.1016/0049-3848(92)90081-K
-
MZ Wojtukiewicz DG Tang KK Nelson 1992 Thrombin enhances tumor cell adhesive and metastatic properties via increased alpha IIb beta 3 expression on the cell surface Thromb Res 68 233 245 10.1016/0049-3848(92)90081-K
-
(1992)
Thromb Res
, vol.68
, pp. 233-245
-
-
Wojtukiewicz, M.Z.1
Tang, D.G.2
Nelson, K.K.3
-
39
-
-
0027481431
-
Thrombin stimulates melanoma tumor-cell binding to endothelial cells and subendothelial matrix
-
A Klepfish MA Greco S Karpatkin 1993 Thrombin stimulates melanoma tumor-cell binding to endothelial cells and subendothelial matrix Int J Cancer 53 978 982
-
(1993)
Int J Cancer
, vol.53
, pp. 978-982
-
-
Klepfish, A.1
Greco, M.A.2
Karpatkin, S.3
-
40
-
-
34248194434
-
Overexpression of protease-activated receptors-1,-2, and -4 (PAR-1, -2, and -4) in prostate cancer
-
10.1002/pros.20503
-
PC Black GJ Mize P Karlin 2007 Overexpression of protease-activated receptors-1,-2, and -4 (PAR-1, -2, and -4) in prostate cancer Prostate 67 743 756 10.1002/pros.20503
-
(2007)
Prostate
, vol.67
, pp. 743-756
-
-
Black, P.C.1
Mize, G.J.2
Karlin, P.3
-
41
-
-
0032482987
-
P-selectin deficiency attenuates tumor growth and metastasis
-
10.1073/pnas.95.16.9325
-
YJ Kim L Borsig NM Varki 1998 P-selectin deficiency attenuates tumor growth and metastasis Proc Natl Acad Sci USA 95 9325 9330 10.1073/pnas.95.16. 9325
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 9325-9330
-
-
Kim, Y.J.1
Borsig, L.2
Varki, N.M.3
-
42
-
-
16544390675
-
Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis
-
10.1158/0008-5472.CAN-03-1054
-
RJ Ludwig B Boehme M Podda 2004 Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis Cancer Res 64 2743 2750 10.1158/0008-5472.CAN-03-1054
-
(2004)
Cancer Res
, vol.64
, pp. 2743-2750
-
-
Ludwig, R.J.1
Boehme, B.2
Podda, M.3
-
43
-
-
0032519957
-
Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents
-
10.1172/JCI1509
-
A Koenig K Norgard-Sumnicht R Linhardt 1998 Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents J Clin Invest 101 877 889 10.1172/JCI1509
-
(1998)
J Clin Invest
, vol.101
, pp. 877-889
-
-
Koenig, A.1
Norgard-Sumnicht, K.2
Linhardt, R.3
-
44
-
-
0027484507
-
Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation
-
RM Nelson O Cecconi WG Roberts 1993 Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation Blood 82 3253 3258
-
(1993)
Blood
, vol.82
, pp. 3253-3258
-
-
Nelson, R.M.1
Cecconi, O.2
Roberts, W.G.3
-
45
-
-
0041765051
-
Visualization of early events in tumor formation of eGFP-transfected rat colon cancer cells in liver
-
10.1053/jhep.2003.50297
-
OR Mook J Van Marle H Vreeling-Sindelarova 2003 Visualization of early events in tumor formation of eGFP-transfected rat colon cancer cells in liver Hepatology 38 295 304 10.1053/jhep.2003.50297
-
(2003)
Hepatology
, vol.38
, pp. 295-304
-
-
Mook, O.R.1
Van Marle, J.2
Vreeling-Sindelarova, H.3
|